Clinical Trial Info

Ivermectin for Severe COVID-19 Management

Authored by

In this multicenter Phase 3 study; it was aimed to investigate the effectiveness and safety of ivermectin use in the treatment of patients with severe COVID-19 pneumonia that have no mutations which alter ivermectin metabolism and cause side effects.


The results of this study can be found here.